AKCEA THERAPEUTICS, INC. — Form D

AKCEA THERAPEUTICS, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2016-01-04. The offering totals $543.2M, of which $543.2M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2016-01-04
• Form: D
• Accession: 0001662524-16-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $543.2M
• Amount sold: $543.2M
• Investors: 1
• Date of first sale: 2015-12-18
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-254386

Issuer

• Name: AKCEA THERAPEUTICS, INC.
• CIK: 0001662524
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 55 CAMBRIDGE PARKWAY, CAMBRIDGE, MA, 02142
• Phone: 760-603-2732

Officers, directors & promoters (8)

More

• CIK 1662524 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search